fragment-based choline kinase inhibitors (Sprint Bioscience/TPP Global Development)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namefragment-based choline kinase inhibitors (Sprint Bioscience/TPP Global Development)
Drug Alias Namefragment-based choline kinase alpha inhibitors (Sprint Bioscience)fragment-based choline kinase inhibitors (Sprint Bioscience)fragment-based choline kinase inhibitors (Sprint Bioscience/TPP Global Development)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholine kinase alpha inhibitors
TargetsCholine kinase alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSprint Bioscience
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIomet Pharma LtdSprint Bioscience
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A